These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5368085)

  • 41. Amino acids and peptides XII: synthetic peptides related to the N-terminal portion of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Tsuji T; Miyano M; Iwamoto M
    Thromb Res; 1989 Dec; 56(6):757-62. PubMed ID: 2633403
    [No Abstract]   [Full Text] [Related]  

  • 42. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
    Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
    Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
    [No Abstract]   [Full Text] [Related]  

  • 43. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contact activation of the plasma coagulation cascade. III. Biophysical aspects of thrombin-binding anticoagulants.
    Vogler EA; Nadeau JG; Graper JC
    J Biomed Mater Res; 1998 Apr; 40(1):92-103. PubMed ID: 9511103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of complex thrombin-heparin formation in the clearance of thrombin in the blood stream and the role of liver and lungs in the absorption of heparin-complexes (author's transl)].
    Kudrjashov BA; Liapina LA; Uljanov AM; Kovaleva TN; Strukova SM
    Thromb Res; 1976 Feb; 8(2):205-15. PubMed ID: 1251351
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin.
    Ostrowski L
    Pol Med J; 1966; 5(6):1197-214. PubMed ID: 5973024
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of carryover of clot activators on coagulation tests during phlebotomy.
    Fukugawa Y; Ohnishi H; Ishii T; Tanouchi A; Sano J; Miyawaki H; Kishino T; Ohtsuka K; Yoshino H; Watanabe T
    Am J Clin Pathol; 2012 Jun; 137(6):900-3. PubMed ID: 22586048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC; Muirhead CR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):397-402. PubMed ID: 5304346
    [No Abstract]   [Full Text] [Related]  

  • 50. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Thrombin: a multifunctional enzyme].
    Polack B
    Ann Biol Clin (Paris); 2003; 61(1):23-31. PubMed ID: 12604383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.
    Pretorius E; Mbotwe S; Bester J; Robinson CJ; Kell DB
    J R Soc Interface; 2016 Sep; 13(122):. PubMed ID: 27605168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits.
    Van Ryn-McKenna J; Merk H; Müller TH; Buchanan MR; Eisert WG
    Thromb Haemost; 1993 Mar; 69(3):227-30. PubMed ID: 8470045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration.
    Traverso CI; Caprini JA; Arcelus JI; Arcelus IM
    Semin Thromb Hemost; 1995; 21 Suppl 4():53-8. PubMed ID: 8747689
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of heparin and dipyridamole on the deposition of fibrin-like material in rabbits infused with soluble fibrin monomer or fibrinogen.
    Lipinski B; Gurewich V; Nowak A; Wetmore R
    Thromb Res; 1974 Sep; 5(3):343-58. PubMed ID: 4439374
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrin and cancer.
    Costantini V; Zacharski LR
    Thromb Haemost; 1993 May; 69(5):406-14. PubMed ID: 8322261
    [No Abstract]   [Full Text] [Related]  

  • 59. Thrombin activity and oral anticoagulant therapy: a further evaluation.
    Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Cadoni MC; Balestrieri A
    Haemostasis; 1990; 20(1):63-4. PubMed ID: 2323681
    [No Abstract]   [Full Text] [Related]  

  • 60. Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting.
    Gurbel PA; Bliden KP; Guyer K; Aggarwal N; Tantry US
    Thromb Res; 2007; 119(5):563-70. PubMed ID: 16806409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.